Literature DB >> 25989800

Comparison of Arthroscopic Microfracture for Osteochondral Lesions of the Talus With and Without Subchondral Cyst.

Keun-bae Lee1, Hyeong-won Park2, Hyun-jong Cho2, Jong-keun Seon2.   

Abstract

BACKGROUND: Although various treatment modalities for an osteochondral lesion of the talus (OLT) with a subchondral cyst have been recommended previously, the primary treatment methods for such conditions have yet to be conclusively determined. Moreover, few comprehensive studies have compared the outcomes of cases where patients were treated with microfracture for OLT with and without subchondral cysts.
PURPOSE: To evaluate the clinical outcomes after arthroscopic microfractures performed as a primary treatment for OLT with a subchondral cyst. STUDY
DESIGN: Cohort study; Level of evidence, 2.
METHODS: The study cohort consisted of 102 patients (102 ankles) who underwent arthroscopic microfracture for small to midsized OLT. The ankles were divided into a cyst group (45 ankles) and a noncyst group (57 ankles).The American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot scale, visual analog scale (VAS), and Ankle Activity Score (AAS) were used to compare the clinical outcomes between the groups over a mean follow-up period of 48 months.
RESULTS: The mean AOFAS ankle-hindfoot scores were 64.8 in the cyst group and 66.2 in the noncyst group preoperatively. These improved to 91.8 and 91.3, respectively, at the final follow-up. The mean VAS scores were 7.5 in the cyst group and 7.3 in the noncyst group preoperatively; these improved to 2.3 and 2.2, respectively, at the final follow-up. The mean AAS in the cyst group and the noncyst group improved from 2.7 and 2.6 preoperatively to 6.7 and 6.5 at the final follow-up, respectively. In terms of radiographic stage improvements, the cyst group showed no change in 18 ankles (40%) and showed improvements of 1 grade in 13 ankles (28.9%), 2 grades in 9 ankles (20%), 3 grades in 3 ankles (6.7%), and 4 grades in 2 ankles (4.4%). The noncyst group showed no change in 17 ankles (29.8%) and showed improvements of 1 grade in 11 ankles (19.3%), 2 grades in 11 ankles (19.3%), 3 grades in 14 ankles (24.6%), and 4 grades in 4 ankles (7.0%). No significant differences were found between the groups in terms of the AOFAS score, VAS score, AAS, or radiographic stage improvements.
CONCLUSION: OLT with and without subchondral cysts treated with arthroscopic microfracture showed similarly good clinical results. The study results suggest that microfracture could be a primary treatment strategy for treating small to midsized OLT regardless of the existence of subchondral cysts.
© 2015 The Author(s).

Entities:  

Keywords:  microfracture; osteochondral lesions; subchondral cyst; talus

Mesh:

Year:  2015        PMID: 25989800     DOI: 10.1177/0363546515584755

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  12 in total

1.  High-Density Autologous Chondrocyte Implantation as Treatment for Ankle Osteochondral Defects.

Authors:  Juan Manuel López-Alcorocho; Isabel Guillén-Vicente; Elena Rodríguez-Iñigo; Ramón Navarro; Rosa Caballero-Santos; Marta Guillén-Vicente; Mercedes Casqueiro; Tomás F Fernández-Jaén; Fernando Sanz; Santiago Arauz; Steve Abelow; Pedro Guillén-García
Journal:  Cartilage       Date:  2019-03-17       Impact factor: 4.634

2.  Results of the osteochondral autologous transplantation for treatment of osteochondral lesions of the talus with harvesting from the ipsilateral talar articular facets.

Authors:  Dong Dong Wan; Heng Huang; Mao Zhong Hu; Quan Yu Dong
Journal:  Int Orthop       Date:  2022-03-25       Impact factor: 3.479

3.  Computed tomography analysis of osteochondral defects of the talus after arthroscopic debridement and microfracture.

Authors:  M L Reilingh; C J A van Bergen; L Blankevoort; R M Gerards; I C M van Eekeren; G M M J Kerkhoffs; C N van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-28       Impact factor: 4.342

4.  Arthroscopic arthrodesis for ankle arthritis without bone graft.

Authors:  Xiaojun Duan; Liu Yang; Li Yin
Journal:  J Orthop Surg Res       Date:  2016-12-01       Impact factor: 2.359

5.  Management of Hepple Stage V Osteochondral Lesion of the Talus with a Platelet-Rich Plasma Scaffold.

Authors:  Wenqi Gu; Tanzhu Li; Zhongmin Shi; Guohua Mei; Jianfeng Xue; Jian Zou; Xiaokang Wang; Haotong Zhang; Hongwei Xu
Journal:  Biomed Res Int       Date:  2017-03-16       Impact factor: 3.411

Review 6.  Current management of talar osteochondral lesions.

Authors:  Arianna L Gianakos; Youichi Yasui; Charles P Hannon; John G Kennedy
Journal:  World J Orthop       Date:  2017-01-18

Review 7.  No superior treatment for primary osteochondral defects of the talus.

Authors:  Jari Dahmen; Kaj T A Lambers; Mikel L Reilingh; Christiaan J A van Bergen; Sjoerd A S Stufkens; Gino M M J Kerkhoffs
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-06-27       Impact factor: 4.342

Review 8.  Midterm Outcomes of Bone Marrow Stimulation for Primary Osteochondral Lesions of the Talus: A Systematic Review.

Authors:  James Toale; Yoshiharu Shimozono; Conor Mulvin; Jari Dahmen; Gino M M J Kerkhoffs; John G Kennedy
Journal:  Orthop J Sports Med       Date:  2019-10-30

9.  One step treatment of talus osteochondral lesions with microfracture and cell free hyaluronic acid based scaffold combination.

Authors:  Necip Selcuk Yontar; Lercan Aslan; Ata Can; Tahir Ogut
Journal:  Acta Orthop Traumatol Turc       Date:  2019-05-21       Impact factor: 1.511

10.  Comparison of autologous osteoperiosteal cylinder and osteochondral graft transplantation in the treatment of large cystic osteochondral lesions of the talus (OLTs): a protocol for a non-inferiority randomised controlled trial.

Authors:  En Deng; Weili Shi; Yanfang Jiang; Qinwei Guo
Journal:  BMJ Open       Date:  2020-02-09       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.